What makes our strategy meetings unique?
Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.
With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.
Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.
Solutions to your Problems
We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.
Industry Researched Topics
We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.
Senior Decision Makers
The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.
Become an official strategy meeting partnerrnWhatever your business needs, we can help. Get in touch for partnering opportunities
Press play to hear what your colleagues had to say...
See the full agenda and facilitator line-uprnDownload the strategy meeting brochure for full details
Meet Our 2022 Facilitators
Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Medicinal Chemistry strategy meeting.
Maneesh PingleHead – Discovery Business Development Sai Life Sciences Ltd
Victoria SteadmanVice President of Business Development and Integrated Partnerships Sai Life Sciences Ltd
Lurong PanFounder and CEO Ainnocence
Norman AzoulayDirector, Scientific Products Excelra
Matthew Segall PhDCEO Optibrium
Tamsin MansleyHead of North American Operations Optibrium
Whitney SmithDirector of Business Development Collaborative Drug Discovery
Sandro BelvedereVice President, Chemistry Avicenna Biosciences, Inc.
Ivan Cornella-TaracidoVP, Translational Chemical Biology Roivant Discovery
Paola CastaldiVP, Chemical Biology & Proteomics LifeMine Therapeutics
Dario DollerVP, Drug Discovery Lucy Therapeutics
Kenneth DuncanVP, Chemistry Accent Therapeutics
Scott EdmondsonSVP, Head of Chemistry Nimbus Therapeutics
Ivan EfremovVP, Head of Medicinal Chemistry Fulcrum Therapeutics
Adam GilbertSenior Scientific Director, Design & Synthesis Sciences Pfizer
Paul GreenspanSenior Director, Discovery Chemistry Takeda
Richard HeidebrechtVice President and R&D Glycologix
Blaise LippaSVP, Molecular Discovery Morphic Therapeutics
Christine LohSVP Biology Nimbus Therapeutics
Jesus MedinaResearch Fellow Arvinas
Ingo MüggeExecutive Director, Head of Modeling & Informatics Alkermes
Patrick Riley, PhDSVP, AI Relay Therapeutics
Nunzio SciammettaDirector, Discovery Chemistry Merck & Co Inc
Huafeng XuCTO Roivant Sciences
Lei ZhangHead of Design, IM Medicinal Chemistry Pfizer